ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.742,04
-0,06%
Dow Jones
42.363,45
0,45%
Euro vs US Dollar
1,11631
-0,12%
Bitcoin
65.763,87
0,89%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. ARCA Biopharma Inc (ABIO)

  7. ARCA Biopharma Inc (ABIO) News

ABIO

ARCA Biopharma (ABIO)

ARCA Biopharma Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ABIO
DatumZeitQuelleÜberschriftSymbolFirma
30/08/202423h57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
29/08/202422h50GlobeNewswire Inc.ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock SplitNASDAQ:ABIOARCA Biopharma Inc
27/08/202401h30GlobeNewswire Inc.ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka TherapeuticsNASDAQ:ABIOARCA Biopharma Inc
23/08/202422h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
23/08/202422h30GlobeNewswire Inc.ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka TherapeuticsNASDAQ:ABIOARCA Biopharma Inc
20/08/202420h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
16/08/202422h27Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ABIOARCA Biopharma Inc
16/08/202422h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
16/08/202422h15GlobeNewswire Inc.ARCA biopharma Declares Special Dividend in Connection with the Proposed Merger with Oruka TherapeuticsNASDAQ:ABIOARCA Biopharma Inc
15/08/202422h17Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ABIOARCA Biopharma Inc
15/08/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
09/08/202414h35Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ABIOARCA Biopharma Inc
01/08/202422h30Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ABIOARCA Biopharma Inc
01/08/202422h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
01/08/202422h15GlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
01/08/202422h10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ABIOARCA Biopharma Inc
01/08/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
26/07/202416h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
25/07/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ABIOARCA Biopharma Inc
24/07/202422h49Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ABIOARCA Biopharma Inc
22/07/202423h17Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:ABIOARCA Biopharma Inc
13/07/202401h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
13/07/202401h10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
09/07/202423h29Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:ABIOARCA Biopharma Inc
09/07/202423h04Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ABIOARCA Biopharma Inc
09/07/202423h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
05/07/202423h20Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ABIOARCA Biopharma Inc
18/06/202423h17Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:ABIOARCA Biopharma Inc
06/06/202422h45Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ABIOARCA Biopharma Inc
22/05/202421h08PR Newswire (US)Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:ABIO

Kürzlich von Ihnen besucht

LSE
AH76
Citi Fun 24
NASDAQ
OPRX
OptimizeRx
BIT
UV4KJ1
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten